Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weight-based Paclitaxel and Carboplatin in Overweight Gynecologic Cancer
NCT02756013Phase 2Terminated
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Apr 2016
- Primary completion
- Aug 2018
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in gynecologic cancer, sponsored by Case Comprehensive Cancer Center. Started Apr 2016; status: terminated.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
gynecologic cancer
Beyond the preview
Go deeper on NCT02756013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02756013.